Lecat, CSY;
Besley, C;
Hough, RE;
Khwaja, A;
Furness, C;
Marks, DI;
Fielding, AK;
(2020)
Inotuzumab ozogamicin versus FLAG-Ida in the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia – real-world resource use data.
Leukemia & Lymphoma
, 61
(2)
pp. 491-493.
10.1080/10428194.2019.1672057.
Preview |
Text
Fielding_Inotuzumab ozogamicin versus FLAG-Ida in the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia_AAM2.pdf - Accepted Version Download (1MB) | Preview |
Archive Staff Only
![]() |
View Item |